Chartier-Harlin MC - Search Results

1

CYP2D6 polymorphism, pesticide exposure, and Parkinson's disease.

Elbaz A, Levecque C, Clavel J, Vidal JS, Richard F, Amouyel P, Alpérovitch A, Chartier-Harlin MC, Tzourio C. Elbaz A, et al. Ann Neurol. 2004 Mar;55(3):430-4. doi: 10.1002/ana.20051. Ann Neurol. 2004. PMID: 14991823

2

Apolipoprotein E and Alzheimer disease: genotype-specific risks by age and sex.

Bickeböller H, Campion D, Brice A, Amouyel P, Hannequin D, Didierjean O, Penet C, Martin C, Pérez-Tur J, Michon A, Dubois B, Ledoze F, Thomas-Anterion C, Pasquier F, Puel M, Demonet JF, Moreaud O, Babron MC, Meulien D, Guez D, Chartier-Harlin MC, Frebourg T, Agid Y, Martinez M, Clerget-Darpoux F. Bickeböller H, et al. Am J Hum Genet. 1997 Feb;60(2):439-46. Am J Hum Genet. 1997. PMID: 9012418 Free PMC article.

3

Distortion of allelic expression of apolipoprotein E in Alzheimer's disease.

Lambert JC, Pérez-Tur J, Dupire MJ, Galasko D, Mann D, Amouyel P, Hardy J, Delacourte A, Chartier-Harlin MC. Lambert JC, et al. Hum Mol Genet. 1997 Nov;6(12):2151-4. doi: 10.1093/hmg/6.12.2151. Hum Mol Genet. 1997. PMID: 9328480

4

A new polymorphism in the APOE promoter associated with risk of developing Alzheimer's disease.

Lambert JC, Pasquier F, Cottel D, Frigard B, Amouyel P, Chartier-Harlin MC. Lambert JC, et al. Hum Mol Genet. 1998 Mar;7(3):533-40. doi: 10.1093/hmg/7.3.533. Hum Mol Genet. 1998. PMID: 9467014

5

Association at LRP gene locus with sporadic late-onset Alzheimer's disease.

Lambert JC, Wavrant-De Vrièze F, Amouyel P, Chartier-Harlin MC. Lambert JC, et al. Lancet. 1998 Jun 13;351(9118):1787-8. doi: 10.1016/s0140-6736(05)78749-3. Lancet. 1998. PMID: 9635959 No abstract available.

6

Pronounced impact of Th1/E47cs mutation compared with -491 AT mutation on neural APOE gene expression and risk of developing Alzheimer's disease.

Lambert JC, Berr C, Pasquier F, Delacourte A, Frigard B, Cottel D, Pérez-Tur J, Mouroux V, Mohr M, Cécyre D, Galasko D, Lendon C, Poirier J, Hardy J, Mann D, Amouyel P, Chartier-Harlin MC. Lambert JC, et al. Hum Mol Genet. 1998 Sep;7(9):1511-6. doi: 10.1093/hmg/7.9.1511. Hum Mol Genet. 1998. PMID: 9700208

7

No pathogenic mutations in the persyn gene in Parkinson's disease.

Lincoln S, Gwinn-Hardy K, Goudreau J, Chartier-Harlin MC, Baker M, Mouroux V, Richard F, Destée A, Becquet E, Amouyel P, Lynch T, Hardy J, Farrer M. Lincoln S, et al. Neurosci Lett. 1999 Jan 4;259(1):65-6. doi: 10.1016/s0304-3940(98)00901-x. Neurosci Lett. 1999. PMID: 10027558

8

No association between the alpha-2 macroglobulin I1000V polymorphism and Alzheimer's disease.

Wavrant-DeVrièze F, Rudrasingham V, Lambert JC, Chakraverty S, Kehoe P, Crook R, Amouyel P, Wu W, Holmans P, Rice F, Pérez-Tur J, Frigard B, Morris JC, Carty S, Cottel D, Tunstall N, Lovestone S, Petersen RC, Chartier-Harlin MC, Goate A, Owen MJ, Williams J, Hardy J. Wavrant-DeVrièze F, et al. Neurosci Lett. 1999 Mar 5;262(2):137-9. doi: 10.1016/s0304-3940(99)00035-x. Neurosci Lett. 1999. PMID: 10203250

9

Is the LDL receptor-related protein involved in Alzheimer's disease?

Lambert JC, Chartier-Harlin MC, Cottel D, Richard F, Neuman E, Guez D, Legrain S, Berr C, Amouyel P, Helbecque N. Lambert JC, et al. Neurogenetics. 1999 Apr;2(2):109-13. doi: 10.1007/s100480050061. Neurogenetics. 1999. PMID: 10369887

10

No pathogenic mutations in the beta-synuclein gene in Parkinson's disease.

Lincoln S, Crook R, Chartier-Harlin MC, Gwinn-Hardy K, Baker M, Mouroux V, Richard F, Becquet E, Amouyel P, Destée A, Hardy J, Farrer M. Lincoln S, et al. Neurosci Lett. 1999 Jul 9;269(2):107-9. doi: 10.1016/s0304-3940(99)00420-6. Neurosci Lett. 1999. PMID: 10430516

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

128 results

Search Page